5-Aminosalicylic Acid, 1,000-mg Caplets versus 500-mg Tablets, in Maintenance of Remission in Ulcerative Colitis
- 1 June 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 24 (4) , 287-288
- https://doi.org/10.1097/00004836-199706000-00026
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trialGastroenterology, 1996
- A Controlled Double Blind Multicenter Study of the Effectiveness of 5-Aminosalicylic Acid in Patients with Crohnʼs Disease in RemissionJournal of Clinical Gastroenterology, 1995
- Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/dayAlimentary Pharmacology & Therapeutics, 1992
- Mesalazine A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Chronic Inflammatory Bowel DiseaseDrugs, 1989
- Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitisGastroenterology, 1988
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Immunosuppressant Therapy of Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1987
- Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Gut, 1980